1. Home
  2. VERV vs AAM Comparison

VERV vs AAM Comparison

Compare VERV & AAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • AAM
  • Stock Information
  • Founded
  • VERV 2018
  • AAM 2024
  • Country
  • VERV United States
  • AAM United States
  • Employees
  • VERV N/A
  • AAM N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • AAM
  • Sector
  • VERV Health Care
  • AAM
  • Exchange
  • VERV Nasdaq
  • AAM Nasdaq
  • Market Cap
  • VERV 382.5M
  • AAM 440.6M
  • IPO Year
  • VERV 2021
  • AAM 2024
  • Fundamental
  • Price
  • VERV $4.79
  • AAM $10.06
  • Analyst Decision
  • VERV Strong Buy
  • AAM
  • Analyst Count
  • VERV 4
  • AAM 0
  • Target Price
  • VERV $25.75
  • AAM N/A
  • AVG Volume (30 Days)
  • VERV 1.4M
  • AAM 153.0K
  • Earning Date
  • VERV 11-05-2024
  • AAM 01-01-0001
  • Dividend Yield
  • VERV N/A
  • AAM N/A
  • EPS Growth
  • VERV N/A
  • AAM N/A
  • EPS
  • VERV N/A
  • AAM N/A
  • Revenue
  • VERV $24,396,000.00
  • AAM N/A
  • Revenue This Year
  • VERV $84.66
  • AAM N/A
  • Revenue Next Year
  • VERV N/A
  • AAM N/A
  • P/E Ratio
  • VERV N/A
  • AAM N/A
  • Revenue Growth
  • VERV 219.91
  • AAM N/A
  • 52 Week Low
  • VERV $4.31
  • AAM $9,600.00
  • 52 Week High
  • VERV $19.34
  • AAM $15,000.00
  • Technical
  • Relative Strength Index (RSI)
  • VERV 32.80
  • AAM N/A
  • Support Level
  • VERV $6.02
  • AAM N/A
  • Resistance Level
  • VERV $6.68
  • AAM N/A
  • Average True Range (ATR)
  • VERV 0.47
  • AAM 0.00
  • MACD
  • VERV -0.14
  • AAM 0.00
  • Stochastic Oscillator
  • VERV 0.25
  • AAM 0.00

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About AAM AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp is a blank check company.

Share on Social Networks: